VALUE ADD PULSE

LIVE
S&P 5007,590.20โ–ผ -0.51%|NASDAQ26,171.40โ–ผ -0.70%|NVDA$221.95โ–ผ -1.40%|MSFT$370.40โ–ฒ +0.05%|AAPL$276.90โ–ฒ +0.40%|GOOGL$335.30โ–ผ -0.15%|META$558.80โ–ฒ +0.10%|AMZN$236.30โ–ผ -0.20%|TSLA$389.90โ–ผ -0.90%|BTC$77,983.80โ–ฒ +1.60%|ETH$2,517.00โ–ฒ +1.50%|VIX22.06โ–ฒ +3.10%|
BREAKING
$2.2B+ priced in one dayWhy One September Day Explains AI Capital's Moodโ—$180M Series DAEO Startup Profound Hits $1.8B In Just 7 Monthsโ—$108M Series CThatch Hits Unicorn Status As Health Costs Surgeโ—FTC Chair Warns AI Labs Against Antitrust Exemptionsโ—Oracle, Microsoft And The Pentagon, By The Numbersโ—$10.8B across 11 roundsEleven US Rounds, $10.8B, Ten Days: September's Real Paceโ—
TC
The Briefing
Trace Cohen ยท Wednesday, September 16
Updated 13h ago

AI-adjacent capital moved on three unrelated fronts today -- two new unicorns in marketing and health benefits, an $8 billion satellite buyout fully funded by public equity -- while the FTC's chair drew a hard line on labs asking for both new rules and an antitrust pass.

THE WIRE in your inboxโ€” Tech, startup & VC news with Trace's take. Free, no spam.

Funding & Deals
6 stories
AI & Technology
6 stories
IPO Watch
6 stories